These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 5254275)

  • 1. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.
    Andersson L; Nilsoon IM; Colleen S; Granstrand B; Melander B
    Ann N Y Acad Sci; 1968 Jun; 146(2):642-58. PubMed ID: 5254275
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
    Okamoto S; Oshiba S; Mihara H; Okamoto U
    Ann N Y Acad Sci; 1968 Jun; 146(2):414-29. PubMed ID: 5254270
    [No Abstract]   [Full Text] [Related]  

  • 3. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
    Thorsen S; Astrup T
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of EACA, PAMBA, AMCA and AMBOCA on fibrinolysis induced by streptokinase, urokinase and tissue activator.
    Westlund LE; Lundén R; Wallén P
    Haemostasis; 1982; 11(4):235-41. PubMed ID: 6982199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antifibrinolytic therapy of gynecologic hemorrhages (literature survey)].
    Skipetrov VP
    Akush Ginekol (Mosk); 1974 Oct; (10):1-6. PubMed ID: 4280255
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of tranexamic acid (AMCA) on postoperative bleeding after conization.
    Rybo G; Westerberg H
    Acta Obstet Gynecol Scand; 1972; 51(4):347-50. PubMed ID: 4566005
    [No Abstract]   [Full Text] [Related]  

  • 7. AMCA (aminomethyl cyclohexane carboxylic acid, Cyklo-kapron) a potent haemostatic agent in urinary tract bleeding.
    Andersson L; Nilsson IM
    Scand J Urol Nephrol; 1969; 3(3):169-76. PubMed ID: 5393836
    [No Abstract]   [Full Text] [Related]  

  • 8. The changes of the tissue plasminogen activator levels in the endometrium during antifibrinolytic therapy.
    Koutský J; Rybák M; Jirásek JE; Hladovec J; Mansfeld V
    Gynaecologia; 1969; 167(4):265-70. PubMed ID: 5767879
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of fibrinolytic hemorrhage with proteinase inhibitors: a preliminary report.
    Ambrus JL; Ambrus CM; Stutzman L; Shimert G; Niswander KR; Woodruff MW; Magoss IV
    Ann N Y Acad Sci; 1968 Jun; 146(2):625-41. PubMed ID: 4239439
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reduction of post-prostatectomy bleeding by medication (experience with the antifibrinolytic agent AMCA)].
    Kaufmann J; Siefker K
    Urologe; 1969; 8(2):57-9. PubMed ID: 5360135
    [No Abstract]   [Full Text] [Related]  

  • 11. Tranexamic acid and fibrinolytic activity of the vessel wall.
    Astedt B; Liedholm P
    Experientia; 1974 Jul; 30(7):776-7. PubMed ID: 4847668
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P
    Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
    [No Abstract]   [Full Text] [Related]  

  • 13. Massive bleeding with fibrinolysis: management with heparin and epsilon aminocaproic acid.
    Bergin JJ; Crosby WH; Jahnke EJ
    Mil Med; 1966 Apr; 131(4):340-4. PubMed ID: 4955920
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental studies on the production of pulmonary infarction. IV. Effects of UK, heparin, t-AMCHA or ellagic acid.
    Hasegawa H; Watanabe N; Kakizaki H; Murata H
    Jpn Heart J; 1973 Jul; 14(4):335-49. PubMed ID: 4542948
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of tranexamic acid in control of haemorrhage after extraction of teeth in haemophilia and Christmas disease.
    Tavenner RW
    Br Med J; 1972 May; 2(5809):314-5. PubMed ID: 4537105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Substances inhibiting fibrinolysis].
    Lakin KM; Rachitskaia NG; Gavrilov AP
    Kardiologiia; 1972 Apr; 12(4):139-53. PubMed ID: 4558033
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-inflammatory effect of the antiplasmin agents, epsilon-aminocaproic acid (EACA) and trans-4-aminomethylcyclohexanecarboxylic acid (AMCHA) in rats].
    Yamasaki H; Tsuji H; Kitamura M
    Nihon Yakurigaku Zasshi; 1967 Nov; 63(6):560-71. PubMed ID: 5627190
    [No Abstract]   [Full Text] [Related]  

  • 18. Tranexamic acid--its use in controlling dental post-operative bleeding in patients with defective clotting mechanisms.
    Pell G
    Br J Oral Surg; 1973 Nov; 11(2):155-64. PubMed ID: 4274285
    [No Abstract]   [Full Text] [Related]  

  • 19. Antifibrinolytic drugs in the treatment of urinary tract haemorrhage.
    Andersson L
    Prog Surg; 1972; 10():76-93. PubMed ID: 4670671
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anaphylactic shock and proteases. Absence of anti-anaphylactic activity in synthetic antifibrinolytic agents in the rabbit].
    Gartenmann C
    Rev Fr Allergol; 1968; 8(1):15-28. PubMed ID: 5719473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.